Aaron Bourret
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Microtubule and mitosis dynamics, Hedgehog Signaling Pathway Studies, Cancer Cells and Metastasis, Chemical Reactions and Isotopes
Most-Cited Works
- → 1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity(2009)106 cited
- → Discovery of NVP‐LEQ506, a Second‐Generation Inhibitor of Smoothened(2013)88 cited
- → Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39(2014)66 cited
- → Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers(2017)52 cited
- → Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4(2009)36 cited
- → Identification and structure–activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway(2008)35 cited
- → Improving dispersed growth of Frankia using Carbopol(2003)7 cited
- → Cover Picture: Discovery of NVP‐LEQ506, a Second‐Generation Inhibitor of Smoothened (ChemMedChem 8/2013)(2013)2 cited
- → Abstract 2974: Targeting cadherin-6 (CDH6) with an antibody-drug conjugate for the treatment of ovarian and renal cancer(2016)1 cited
- → Supplementary Figure Legends from Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers(2023)